bioAffinity Technologies, Inc. (BIAF)
NASDAQ: BIAF · Real-Time Price · USD
1.235
-0.035 (-2.75%)
Nov 21, 2024, 3:59 PM EST - Market closed
bioAffinity Technologies Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Cash & Equivalents | 0.76 | 2.82 | 11.41 | 1.36 | 0.08 |
Cash & Short-Term Investments | 0.76 | 2.82 | 11.41 | 1.36 | 0.08 |
Cash Growth | -83.22% | -75.28% | 738.85% | 1537.19% | - |
Accounts Receivable | 1.33 | 0.78 | - | 0 | - |
Other Receivables | - | 0.03 | 0.01 | - | 0 |
Receivables | 1.33 | 0.81 | 0.01 | 0 | 0 |
Inventory | 0.03 | 0.02 | 0.01 | - | - |
Prepaid Expenses | 0.44 | 0.17 | 0.34 | 0.02 | 0.01 |
Other Current Assets | - | 0.15 | 0.19 | 0.06 | 0.02 |
Total Current Assets | 2.55 | 3.97 | 11.96 | 1.44 | 0.12 |
Property, Plant & Equipment | 1.79 | 1.99 | 0.21 | 0 | 0.01 |
Goodwill | 1.4 | 1.4 | - | - | - |
Other Intangible Assets | 0.79 | 0.83 | - | - | - |
Long-Term Deferred Charges | - | - | - | 0.01 | - |
Other Long-Term Assets | 0.02 | 0.02 | 0.01 | 0 | 0.02 |
Total Assets | 6.55 | 8.22 | 12.18 | 1.45 | 0.15 |
Accounts Payable | 0.78 | 0.6 | 0.35 | 0.23 | 0.19 |
Accrued Expenses | 0.9 | 1.15 | 0.54 | 1.6 | 0.98 |
Short-Term Debt | - | - | 0.25 | 11.15 | 9.77 |
Current Portion of Long-Term Debt | 0.27 | - | - | 0.05 | 0.19 |
Current Portion of Leases | 0.51 | 0.46 | - | - | - |
Current Unearned Revenue | 0.02 | 0.03 | - | - | - |
Total Current Liabilities | 2.49 | 2.25 | 1.14 | 13.04 | 11.12 |
Long-Term Debt | 0.02 | - | - | 0.16 | 0.05 |
Long-Term Leases | 0.92 | 1.12 | - | - | - |
Total Liabilities | 3.43 | 3.37 | 1.14 | 13.2 | 11.17 |
Common Stock | 0.09 | 0.07 | 0.06 | 0.02 | 0.02 |
Additional Paid-In Capital | 53.71 | 49.39 | 47.65 | 12.7 | 7.1 |
Retained Earnings | -50.68 | -44.6 | -36.67 | -28.51 | -22.19 |
Total Common Equity | 3.12 | 4.86 | 11.04 | -15.79 | -15.07 |
Shareholders' Equity | 3.12 | 4.86 | 11.04 | -11.75 | -11.03 |
Total Liabilities & Equity | 6.55 | 8.22 | 12.18 | 1.45 | 0.15 |
Total Debt | 1.72 | 1.58 | 0.25 | 11.36 | 10.01 |
Net Cash (Debt) | -0.96 | 1.24 | 11.16 | -10 | -9.92 |
Net Cash Growth | - | -88.86% | - | - | - |
Net Cash Per Share | -0.09 | 0.14 | 2.48 | -3.74 | -3.71 |
Filing Date Shares Outstanding | 12.39 | 11.51 | 8.46 | 2.73 | 2.67 |
Total Common Shares Outstanding | 12.39 | 9.39 | 8.38 | 2.68 | 2.67 |
Working Capital | 0.06 | 1.72 | 10.82 | -11.6 | -11 |
Book Value Per Share | 0.25 | 0.52 | 1.32 | -5.90 | -5.64 |
Tangible Book Value | 0.93 | 2.62 | 11.04 | -15.79 | -15.07 |
Tangible Book Value Per Share | 0.07 | 0.28 | 1.32 | -5.90 | -5.64 |
Machinery | - | 0.82 | 0.48 | 0.26 | 0.26 |
Leasehold Improvements | - | 0.01 | - | - | - |
Source: S&P Capital IQ. Standard template. Financial Sources.